First adjuvanted quadrivalent influenza vaccine by Seqirus receives EU approval

8 June 2020 - The European Commission has today given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become ...

Read more →

Influenza vaccines released for 2020 season

8 May 2020 - Six influenza vaccines are available in Australia in 2020. All of these vaccines are quadrivalent, which ...

Read more →

2020 seasonal influenza vaccines

13 March 2020 - The Australian Influenza Vaccine Committee has reviewed data related to epidemiology, antigenic and genetic characteristics of ...

Read more →

Seqirus announces U.S. FDA approval of its first-ever adjuvanted, cell-based pandemic influenza A (H5N1) vaccine

3 February 2020 - Seqirus, a global leader in influenza prevention and pandemic response, today announced that the U.S. FDA ...

Read more →

Novavax granted fast track designation for NanoFlu in older adults

15 January 2020 - Novavax today announced that the U.S. FDA has granted fast track designation for NanoFlu, its recombinant quadrivalent ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

Seqirus receives FDA approval of Afluria Quadrivalent (influenza vaccine) for people six months of age and older in the U.S.

17 October 2018 - Seqirus today announced the U.S. FDA has approved Afluria Quadrivalent (influenza vaccine) for use in people ...

Read more →

Update of EU recommendations for 2018/2019 seasonal flu vaccine composition

30 April 2018 - Update to recommendations issued in March 2018. ...

Read more →

2018 influenza vaccines now available

18 April 2018 - More than 4.5 million Australians who are most at risk of getting sick during this year’s flu ...

Read more →

2018 seasonal influenza vaccines

27 March 2018 - This year, four quadrivalent and two trivalent influenza vaccines will be available. ...

Read more →

EU recommendations for 2018/2019 seasonal flu vaccine composition

26 March 2018 - EU advice based on WHO recommendations. ...

Read more →

Statement from FDA Commissioner on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines

26 February 2018 - The current influenza season has been especially difficult, causing widespread illness that has affected all fifty ...

Read more →

Seqirus receives FDA approval for Afluria Quadrivalent (influenza vaccine) for people 18 years of age and older

29 August 2016 - Seqirus is shipping trivalent and quadrivalent formulations of Afluria in the 2016-2017 influenza season. ...

Read more →

TGA approves Afluria Quad

28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine). ...

Read more →

FDA approves CSL's Flucelvax quadrivalent influenza vaccine

24 May 2016 - CSL today announced that the US FDA has approved Seqirus’ Flucelvax Quadrivalent (Influenza Vaccine), the first four-strain, ...

Read more →